Logo-ijhpm
Int J Health Policy Manag. 2018;7(2): 112-119. doi: 10.15171/ijhpm.2017.128
PMID: 29524935        PMCID: PMC5819371

Short Communication

Towards Patient-Centered Conflicts of Interest Policy

Peter D. Young 1 * , Dawei Xie 2, Harald Schmidt 3,4

Cited by CrossRef:

1- Safavi K, Hong A, Janney C, Panchbhavi V, Jupiter D. Sunshine Act in the dark. Clinical Ethics. 2022;17(2):122 [Crossref]
2- Stoll M, Hubenschmid L, Koch C, Lieb K, Egloff B. Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey. BMJ Open. 2022;12(6):e055963 [Crossref]
3- McCoy M. Industry Support of Patient Advocacy Organizations: The Case for an Extension of the Sunshine Act Provisions of the Affordable Care Act. Am J Public Health. 2018;108(8):1026 [Crossref]
4- Chen X. Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space. Health Care Anal. 2022;30(1):35 [Crossref]
5- DeTora L, Citrome L. Disclosures and Conflicts of Interest: Solving the Riddle, Wrapped in a Mystery, Inside an Enigma. Clinical Therapeutics. 2019;41(12):2643 [Crossref]
6- Woo J, Butler A, Jayaram N, Karamlou T, LaPar D, Anderson B. Center Reputation and Experience Relate to Industry Payments to Congenital Heart Disease Providers. The Annals of Thoracic Surgery. 2021;112(6):2039 [Crossref]
7- Rulon Z, Powers K, Anderson J, Weaver M, Johnson A, Hartwell M, Vassar M. Conflicts of Interest Among Authors of Systematic Reviews and Meta-analyses Investigating Interventions for Melanoma: Cross-sectional Literature Study. JMIR Dermatol. 2021;4(1):e25858 [Crossref]
8- Kolarich A, Pang S, Solomon A, England R, Georgiades C. Increasing Consulting Fee Payments to Interventional Radiologists in the United States From Industry, 2014 to 2018: Analysis of the Open Payments Database. Journal of the American College of Radiology. 2021;18(12):1668 [Crossref]
9- Hosseinzadeh Roknabadi E, Vatankhah S, Gorji H, Behzadifar M, Aryankhesal A. Strategies for Management of Conflict of Interests in the Pharmaceutical Sector: A Systematic Review. Health Scope. 2024;13(4) [Crossref]
10- Kanter G, Carpenter D, Lehmann L, Mello M. US Nationwide Disclosure of Industry Payments and Public Trust in Physicians. JAMA Netw Open. 2019;2(4):e191947 [Crossref]
11- Bhardwaj P, Kumar J, Yadav R. Patients Driving the Clinical Trial Designs – Democracy in Clinical Research. RRCT. 2019;14(4):237 [Crossref]
12- Kanter G, Carpenter D, Lehmann L, Mello M. Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment. BMJ Open. 2019;9(2):e024020 [Crossref]